Accumulating evidence indicates that CRP, an essential indicator of the inflammatory process, has been identified as an independent risk factor for cardiovascular and cerebrovascular diseases.[5] However, it is unclear whether the coexistence of elevated CRP and HCY levels accelerates the risk of sleep disorders during the MT period. The gene discussed is CRP; the disease is sleep disorder.